Skip to content
Screener

Eli Lilly LLY Reportable Segment — Net Income

Similar metrics at other companies

Analog Devices logo
ADIReportable Segment — Net Income
$1.18B+106%
Adobe logo
ADBEReportable Segment — Net Income
$1.71B+1.2%
Credo Technology Group Holding Ltd logo
CRDOReportable Segment — Net Income
$169.1M+362%
Zoom Video Communications, Inc. logo
ZMReportable Segment — Net Income
$425.68M+67.2%
Veeva Systems logo
VEEVReportable Segment — Net Income
$260.94M+14.4%
DocuSign logo
DOCUReportable Segment — Net Income
$78.2M+8.5%

Other financials

Income statement

See full
Revenue$23.0B+47.7%
Gross profit$19.7B+50.3%
Net income$7.1B+25.3%
EPS (diluted)$7.94+26.2%

Balance sheet

See full
Cash & equivalents$9.0B+165%
Total debt$54.9B+37.6%
Total equity$33.9B+85.4%
Total assets$142.28B+41.0%

Cash flow

See full
Operating cash flow$10.7B+246%
CapEx$2.9B+72.8%
Free cash flow$7.8B+458%

Valuation

See full
Market cap$1.06T+58.6%
Enterprise value$1.11T+56.9%
P/E39.8×-8.8×
P/S13.3×+0.8×

Profitability

See full
Gross margin83.4%+0.8pp
Net margin33.5%+7.6pp
FCF margin22.8%+13.7pp

Returns & leverage

See full
Return on equity102.4%+15.7pp
Debt / equity1.6×-0.6×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Eli Lilly’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:40 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000059478-26-000081
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
13,7278,78124,67618,053
Income before income taxes9,2476,77718,09710,233
Income taxes2,1521,1163,6061,813
Net income$7,095$5,661$14,491$8,420
Earnings per share:
Basic$7.95$6.30$16.22$9.37
Diluted$7.94$6.29$16.19$9.35
Shares used in calculation of earnings per share:

Item 1. Financial Statements

FAQ

What is Eli Lilly's reportable segment — net income?
Eli Lilly (LLY) reported reportable segment — net income of $7.1B in Q2 2026.
How has Eli Lilly's reportable segment — net income changed year-over-year?
Eli Lilly's reportable segment — net income increased by 25.3% year-over-year, from $5.66B to $7.1B.
What is the long-term trend for Eli Lilly's reportable segment — net income?
Over 3 years (2022 to 2025), Eli Lilly's reportable segment — net income has grown at a 49.0% compound annual growth rate (CAGR), from $6.24B to $20.64B.
What does reportable segment — net income mean?
Represents the final profitability of the segment after accounting for all revenues, operating expenses, and other segment-specific charges. This is the primary measure of the segment's contribution to the overall enterprise's bottom line. It serves as the ultimate benchmark for the segment's financial health and operational success.

Ask your AI about Eli Lilly's reportable segment — net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude